Gastroenterology Education and CPD for trainees and specialists » Inflammatory Bowel disease https://www.gastrotraining.com Largest online gastroenterology, hepatology and endoscopy education and training resource with histology, x-ray images, videos, gastro calculators, and MCQs. Thu, 04 Dec 2025 21:29:42 +0000 en-US hourly 1 http://wordpress.org/?v= Adverse events do not outweigh benefits of combination therapy for Crohn’s disease in a decision analytic model. http://www.ncbi.nlm.nih.gov/pubmed/21963958 http://www.ncbi.nlm.nih.gov/pubmed/21963958#comments Wed, 25 Jan 2012 18:18:06 +0000 GastrotrainingAdmin http://www.gastrotraining.com/?p=7018 http://www.ncbi.nlm.nih.gov/pubmed/21963958/feed 0 Switch to adalimumab in patients with Crohn’s disease controlled by maintenance infliximab: prospective randomised SWITCH trial. http://www.ncbi.nlm.nih.gov/pubmed/21948942 http://www.ncbi.nlm.nih.gov/pubmed/21948942#comments Wed, 28 Dec 2011 21:56:04 +0000 GastrotrainingAdmin http://www.gastrotraining.com/?p=6981 http://www.ncbi.nlm.nih.gov/pubmed/21948942/feed 0 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. http://www.ncbi.nlm.nih.gov/pubmed/21407180 http://www.ncbi.nlm.nih.gov/pubmed/21407180#comments Tue, 27 Sep 2011 20:35:27 +0000 GastrotrainingAdmin http://www.gastrotraining.com/?p=6733 http://www.ncbi.nlm.nih.gov/pubmed/21407180/feed 0 Infliximab, azathioprine, or combination therapy for Crohn’s disease. http://www.ncbi.nlm.nih.gov/sites/entrez/20393175?dopt=Abstract&holding=f1000%2Cf1000m http://www.ncbi.nlm.nih.gov/sites/entrez/20393175?dopt=Abstract&holding=f1000%2Cf1000m#comments Sat, 27 Nov 2010 12:06:10 +0000 Gastro Training http://www.gastrotraining.com/?p=5763 http://www.ncbi.nlm.nih.gov/sites/entrez/20393175?dopt=Abstract&holding=f1000%2Cf1000m/feed 0